Listed

Central Garden & Pet Co: Form 10-Q for the period ended Jun 25, 2022

Filed with the SEC on Aug 4, 2022 and accepted by EDGAR at Aug 4, 2022, 13:07 ET.

Share

Management's discussion and analysis

As filed, 60,163 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our Company

Central Garden & Pet Company (“Central”) is a market leader in the garden and pet industries in the United States. For over 40 years, Central has proudly nurtured happy and healthy homes by bringing innovative and trusted solutions to consumers and its customers. We manage our operations through two reportable segments: Pet and Garden.

Our pet segment includes dog and cat supplies such as dog treats and chews, toys, pet beds and grooming products, waste management and training pads, pet containment, supplies for aquatics, small animals, reptiles and pet birds including toys, cages and habitats, bedding, food and supplements, products for equine and livestock, animal and household health and insect control products, live fish and small animals as well as outdoor cushions. These products are sold under brands such as Aqueon®, Cadet®, Comfort Zone®, Farnam®, Four Paws®, K&H Pet Products® ("K&H"), Kaytee®, Nylabone® and Zilla®.

Our garden segment includes lawn and garden consumables such as grass, vegetable, flower and herb seed, wild bird feed, bird houses and other birding accessories, weed, grass, and other herbicides, insecticide and pesticide products, fertilizers and live plants. These products are sold under brands such as Amdro®, Ferry-Morse®, Pennington® and Sevin®.

In fiscal 2021, our consolidated net sales were $3.3 billion, of which our Pet segment, or Pet, accounted for approximately $1.9 billion and our Garden segment, or Garden, accounted for approximately $1.4 billion. In fiscal 2021, our operating income was $254 million consisting of income from our Pet segment of $208 million, income from our Garden segment of $139 million and corporate expenses of $93 million.

We were incorporated in Delaware in May 1992 as the successor to a California corporation that was formed in 1955. Our executive offices are located at 1340 Treat Boulevard, Suite 600, Walnut Creek, California 94597, and our telephone number is (925) 948-4000. Our website is www.central.com (http://www.central.com). The information on our website is not incorporated by reference in this quarterly report.

Recent Developments

Fiscal 2022 Third Quarter Financial Performance:

  • Net sales decreased $21.7 million, or 2.1%, from the prior year quarter to $1,015.4 million. Pet segment sales decreased $3.0 million, and Garden segment sales decreased $18.7 million.
  • Organic net sales declined 4.5%, due primarily to an 8.3% decrease in our Garden segment.
  • Gross profit decreased $12.7 million from the prior year quarter, and gross margin decreased 60 basis points to 30.3%.
  • Selling, general and administrative expense decreased $13.5 million from the prior year quarter to $193.5 million and as a percentage of net sales decreased 90 basis points to 19.1%.
  • Operating income increased $0.8 million, or 0.7%, from the prior year quarter, to $114.1 million.
  • Net income in the third quarter of fiscal 2022 was $75.4 million, or $1.39 per diluted share, compared to net income of $76.2 million, or $1.37 per diluted share, in the third quarter of fiscal 2021.

COVID-19 Impact

COVID-19 has led to adverse impacts on human health, the global economy and society at large. From the beginning, our priority has been the safety of our employees, customers and consumers.

Central has been impacted by COVID-19 in a number of ways, including increased demand and sales. The increased demand for our products challenged our supply chain and our ability to procure and manufacture enough product to meet the high levels of demand. At some of our facilities, we experienced reduced productivity and increased employee absences, which may continue during the balance of the pandemic. Our manufacturing facilities and distribution centers are currently open and operational. We have incurred and will continue to incur additional costs including personal protective equipment and sanitation costs. We have hosted mobile vaccination clinics at some of our larger manufacturing and distribution sites, in order to make vaccines available to our employees.

The pandemic and related increase in demand created operational challenges, which have impacted our service and fill rates. While they have improved in fiscal 2022, they have yet to return to our historical rates. Our supply chain experienced disruptions and delays which resulted in increased operational and logistics costs. To mitigate the impact of supply constraints of commodity, materials, freight and labor and extended inventory transit times and the resulting impact on our service and fill rates, we increased inventory levels in fiscal 2022. We may experience additional disruptions in our supply chain as the pandemic continues, although we cannot reasonably estimate the potential impact or timing of those events, and we may not be able to mitigate such impact. We continue to face supply chain challenges with high inflation in commodities, materials, labor and freight and the limited availability of labor. Inflationary pressures continue to result in significant increases in costs for commodities, materials, labor and freight.

We believe we have sufficient liquidity to satisfy our cash needs with our cash and revolving credit facility as we manage through the current economic and health environment.

While vaccination efforts and the easing of government restrictions have signaled an improving health environment, the timing of a full recovery remains uncertain. Forecasting and planning remain challenging in the current environment and will continue to be challenging as the pandemic eases in the future. In the current uncertain environment, our employees, customers and consumers will continue to be our priority as we manage our business to deliver long-term growth.

Results of Operations

Three Months Ended June 25, 2022

Compared with Three Months Ended June 26, 2021

Net Sales

Net sales for the three months ended June 25, 2022 decreased $21.7 million, or 2.1%, to $1,015.4 million from $1,037.1 million for the three months ended June 26, 2021. Organic net sales, which exclude the impact of acquisitions and divestitures in the last 12 months, decreased $46.8 million, or 4.5%, as compared to the fiscal 2021 quarter. Our branded product sales decreased $12.4 million, and sales of other manufacturers’ products decreased $9.3 million. Although we have taken pricing actions across our businesses to mitigate high inflation in commodities, materials, freight and labor, the favorable impact on net sales was more than offset by volume declines.

Pet net sales decreased $3.0 million, or 0.6%, to $504.8 million for the three months ended June 25, 2022 from $507.8 million for the three months ended June 26, 2021. Unit volume declines were partially offset by pricing actions taken to respond to the current inflationary operating environment. Decreases in net sales in our dog bed business were partially offset by increases in sales in our dog and cat treats and toy business and our outdoor cushion business. The decrease in our dog bed business was due to a purposeful SKU rationalization. The increase in sales in our dog and cat treats and toy business was due to pricing actions taken to offset inflationary pressures; and the increase in our outdoor cushion business was due primarily to better fill rates resulting primarily from supply chain improvements. Pet branded product sales declined $7.0 million while sales of other manufacturers' products increased $4.0 million.

Garden net sales decreased $18.7 million, or 3.5%, to $510.6 million for the three months ended June 25, 2022 from $529.3 million for the three months ended June 26, 2021. Organic sales decreased $43.8 million, or 8.3%, due primarily to unfavorable weather and reduced consumer purchasing resulting from higher prices in the current inflationary environment and the potential of recession. Sales volume declines have been partially offset by pricing actions taken to offset rising costs. Most of our garden businesses had decreased sales in the quarter with the exception of wild bird feed which benefited from price increases taken to offset significant commodity inflation. Garden branded sales decreased $5.4 million, while sales of other manufacturers' products decreased $13.3 million.

Gross Profit

Gross profit for the three months ended June 25, 2022 decreased $12.7 million, or 4.0%, to $307.6 million from $320.3 million for the three months ended June 26, 2021. Gross margin decreased 60 basis points to 30.3% for the three months ended June 25, 2022 from 30.9% for the three months ended June 26, 2021. Both operating segments, excluding the impact of the purchase accounting inventory markup in the Garden segment in the prior year, contributed to the decline in gross profit and gross margin. The decreases in gross profit and gross margin were driven by significant cost inflation in commodities, labor, and freight, partially offset by the pricing actions taken to combat the inflationary environment and by the impact of our fiscal 2021 acquisitions. Overall, our gross margins continue to be under pressure from the current inflationary environment and we continue to experience cost increases, primarily in commodities, labor and freight. We intend to continue to seek price increases to help offset the rising costs, but there is no assurance that we will be successful in fully offsetting the impact of cost increases.

Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased $13.5 million, or 6.5%, to $193.5 million for the three months ended June 25, 2022. As a percentage of net sales, selling, general and administrative expenses decreased to 19.1% for the three months ended June 25, 2022, compared to 20.0% in the comparable prior year quarter. Both operating segments and corporate had lower selling, general and administrative expenses in the quarter. Additionally, we have now lapped three of the four Garden segment acquisitions completed in fiscal 2021 and, as such, their operations are included in the prior year quarter's results. The decrease in selling, general and administrative expense was due to lower delivery costs, most notably in our Garden segment, and lower variable compensation amounts.

Selling and delivery expense decreased $9.9 million to $97.8 million for the three months ended June 25, 2022. The decrease was due primarily to lower sales and delivery volumes, most notably in our Garden segment, and a change in a customer's shipping terms.

Warehouse and administrative expense decreased $3.6 million, or 3.6%, to $95.8 million for the three months ended June 25, 2022. The decrease was due primarily to reduced variable compensation partially offset by higher lease costs for several renewed facility leases. Corporate expenses declined $0.7 million due primarily to lower variable compensation amounts partially offset by increased payroll related costs from headcount additions. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resources, and information technology functions.

Operating Income

Operating income increased $0.8 million, or 0.7%, to $114.1 million for the three months ended June 25, 2022. The increase in operating income was due to decreased selling, general and administrative expense partially offset by lower sales and gross profit. Our operating margin increased 30 basis points to 11.2% as compared to the prior year quarter, as selling, general and administrative expense as a percentage of sales declined 90 basis points, which more than offset the 60 basis point decline in gross margin due primarily to cost increases in the current inflationary environment.

Pet operating income decreased $8.4 million, or 11.8%, to $62.6 million for the three months ended June 25, 2022. Pet operating income decreased due to a decline in sales and lower gross profit partially offset by lower selling, general and administrative expense. Pet operating margin decreased 160 basis points to 12.4% due primarily to higher input costs in the current inflationary environment resulting in a lower gross margin.

Garden operating income increased $8.5 million to $75.6 million for the three months ended June 25, 2022 from $67.0 million for the three months ended June 26, 2021. Garden operating income increased due to lower selling, general and administrative expense partially offset by lower sales. Garden operating margin increased 210 basis points to 14.8% due primarily to an improved gross margin (favorably impacted by increased pricing and the lack of purchase accounting inventory markups that impacted the prior year gross margin) and the reduction in selling, general and administrative expense as a percentage of net sales.

Corporate expense decreased $0.7 million, or 2.9%, to $24.1 million for the three months ended June 25, 2022 from $24.8 million for the three months ended June 26, 2021. Corporate expense decreased due primarily to lower variable compensation amounts partially offset by increased salary and wages from headcount additions.

Net Interest Expense

Net interest expense for the three months ended June 25, 2022 increased $1.2 million, or 9.5%, to $14.3 million due primarily to a higher debt balance outstanding during the quarter. In April 2021, we issued $400 million aggregate principal amount of 4.125% senior notes due April 2031. Debt outstanding on June 25, 2022 was $1,186.2 million compared to $1,183.7 million at June 26, 2021.

Other Income (Expense)

Other income (expense) is comprised of income or losses from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses. Other income (expense) was an expense of $0.8 million for the quarter ended June 25, 2022 compared to an expense of $1.1 million for the quarter ended June 26, 2021. The decrease in expense was due primarily to the impairment of an investment in the prior year quarter partially offset by foreign currency losses in the current year quarter.

Income Taxes

Our effective income tax rate was 23.7% for the quarter ended June 25, 2022 and 22.5% for the quarter ended June 26, 2021. The increase in our effective income tax rate was due primarily to lower excess tax benefits from stock compensation in the current year quarter as compared to the prior year quarter.

Net Income and Earnings Per Share

Our net income in the third quarter of fiscal 2022 was $75.4 million, or $1.39 per diluted share, compared to a net income of $76.2 million, or $1.37 per diluted share, in the third quarter of fiscal 2021.

Nine Months Ended June 25, 2022

Compared with Nine Months Ended June 26, 2021

Net Sales

Net sales for the nine months ended June 25, 2022 increased $66.5 million, or 2.6%, to $2,631.1 million from $2,564.6 million for the nine months ended June 26, 2021. Organic net sales declined $76.5 million, or 3.0%, as compared to the prior year nine-month period. Generally, in both operating segments, volume declines were only partially offset by increased prices in response to high inflation. Our branded product sales increased $74.7 million, and sales of other manufacturers’ products decreased $8.2 million.

Pet net sales increased $2.2 million, or 0.2%, to $1,438.4 million for the nine months ended June 25, 2022 from $1,436.2 million for the nine months ended June 26, 2021. Net sales in the prior year period include sales from the Breeder’s Choice business unit, which we sold in December 2020. Organic net sales increased $6.1 million, or 0.4%, as compared to the prior year nine-month period. The organic sales improvement was driven by increased pricing with notable sales increases in our dog and cat treats and toy business, outdoor cushion business and animal health business, partially offset by a volume based sales decrease in our dog bed business due primarily to SKU rationalization. Pet branded sales decreased $7.1 million, and sales of other manufacturer's products increased $9.3 million.

Garden net sales increased $64.3 million, or 5.7%, to $1,192.7 million for the nine months ended June 25, 2022 from $1,128.4 million for the nine months ended June 26, 2021. Organic sales decreased $82.6 million, or 7.3%, while sales from recent acquisitions contributed $146.9 million. The organic sales decrease was due primarily to unfavorable weather and changing consumer behavior in response to high inflation and a potential recession. Most of our garden businesses had decreased sales with the exception of wild bird feed which benefited from price increases taken to offset large commodity inflation. Garden branded sales increased $81.8 million, while sales of other manufacturers’ products decreased $17.5 million.

Gross Profit

Gross profit for the nine months ended June 25, 2022 increased $34.5 million, or 4.5%, to $792.6 million from $758.1 million for the nine months ended June 26, 2021. Gross margin improved 50 basis points to 30.1% for the nine months ended June 25, 2022 from 29.6% for the nine months ended June 26, 2021. Both Pet and Garden contributed to the increase in gross profit and gross margin although the increase was driven primarily by the Garden segment. Both segments are being impacted by the rapidly increasing cost environment. We have implemented and intend to continue to seek price increases to help offset the rising costs but do not anticipate we will be able to fully offset the cost pressures in fiscal 2022. Although our gross margin increased in the current nine-month period, as compared to the prior year nine-month period, our operating margin declined during the current nine-month period.

In the Pet segment, the improved gross profit and margin were due primarily to price increases taken to combat inflation and a favorable product mix partially offset by increased commodity, freight and labor costs.

In the Garden segment, the improved gross profit and margin were due primarily to price increases and the favorable impact of our fiscal 2021 acquisitions, which included the impact of purchase accounting in fiscal 2021 and the impact on our product mix in the current year, partially offset by increased commodity, freight and labor costs.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $32.3 million, or 6.3%, to $545.5 million for the nine months ended June 25, 2022 from $513.2 million for the nine months ended June 26, 2021. As a percentage of net sales, selling, general and administrative expenses increased to 20.7% for the nine months ended June 25, 2022 from 20.0% for the comparable prior year nine-month period.

Selling and delivery expense increased $7.1 million, or 2.8%, to $264.2 million for the nine months ended June 25, 2022 from $257.1 million for the nine months ended June 26, 2021. The increase was due primarily to the addition of the fiscal 2021 acquisitions in our Garden segment and marketing investments for brand development.

Warehouse and administrative expense increased $25.2 million, or 9.8%, to $281.3 million for the nine months ended June 25, 2022. The increased expense was driven by the addition of our four fiscal 2021 acquisitions in the Garden segment. Additionally, both operating segments experienced increased labor, delivery, fuel and rental expenses due to the current inflationary environment. Corporate expenses increased $4.1 million due primarily to increased payroll related costs due to headcount increases and non-cash equity compensation partially offset by lower variable compensation expense.

Operating Income

Operating income increased $2.2 million to $247.1 million for the nine months ended June 25, 2022 from $244.9 million for the nine months ended June 26, 2021. Our operating margin declined slightly to 9.4% for the nine months ended June 25, 2022 from 9.5% for the nine months ended June 26, 2021. Increased sales and a 50 basis point improvement in gross margin were more than offset by an increase in selling, general and administrative expense.

Pet operating income decreased $8.1 million, or 4.6%, to $168.5 million for the nine months ended June 25, 2022 from $176.6 million for the nine months ended June 26, 2021. Pet operating income decreased as an increase in selling, general and administrative expense was only partially offset by minor increases in sales and gross profit. Pet operating margin declined 60 basis points due to higher selling, general and administrative expense as a percentage of net sales which was partially offset by an increase in gross margin.

Garden operating income increased $14.5 million to $152.1 million for the nine months ended June 25, 2022. Garden operating income increased due to increased sales and gross profit partially offset by higher selling, general and administrative expense. Garden operating margin improved 60 basis points to 12.8% due to an improved gross margin partially offset by higher selling, general and administrative expense as a percentage of net sales.

Corporate operating expense increased $4.1 million to $73.5 million in the current nine-month period from $69.4 million in the comparable fiscal 2021 period due primarily to increased payroll related costs due to headcount increases and non-cash equity compensation partially offset by lower variable compensation expense.

Net Interest Expense

Net interest expense for the nine months ended June 25, 2022 decreased $0.6 million, or 1.3%, to $43.4 million from $44.0 million for the nine months ended June 26, 2021. In the prior year nine-month period, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030 and used the proceeds to redeem all of our outstanding aggregate principal amount 6.125% senior notes due 2023 with the remainder for general corporate purposes. As a result of our redemption of the 2023 Notes, we recognized incremental interest expense in the prior year nine-month period of approximately $10.0 million. Partially offsetting the reduction from the prior year’s incremental interest expense was increased interest expense in the current year quarter related to our issuance in April 2021 of $400 million aggregate principal amount of 4.125% senior notes due April 2031.

Debt outstanding on June 25, 2022 was $1,186.2 million compared to $1,183.7 million at June 26, 2021. Our average borrowing rate for the nine months ended June 25, 2022 increased to 4.5% from 4.4% for the nine months ended June 26, 2021.

Other Income (Expense)

Other income (expense) was an expense of $1.3 million for the nine-month period ended June 25, 2022 compared to income of $0.4 million for the nine-month period ended June 26, 2021, due primarily to foreign currency losses in the current nine-month period.

Income Taxes

Our effective income tax rate was 23.4% for the nine-month period ended June 25, 2022 compared to 22.5% for the nine-month period ended June 26, 2021. The increase in our effective income tax rate was due primarily to lower excess tax benefits from stock compensation in the current nine-month period.

Net Income and Earnings Per Share

Our net income for the nine months ended June 25, 2022 was $154.1 million, or $2.82 per diluted share, compared to $154.8 million, or $2.80 per diluted share, for the nine months ended June 26, 2021.

Use of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including non-GAAP net income and diluted net income per share, adjusted EBITDA and organic sales. Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.

Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense, depreciation and amortization and stock-based compensation (or operating income plus depreciation and amortization and stock-based compensation expense). We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluation. Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable.

We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

Non-GAAP financial measures reflect adjustments based on the following items:

  • Incremental expenses from note redemption and issuance: we have excluded the impact of the incremental expenses incurred from the note redemption and issuance as they represent an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of these expenses supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
  • Loss on sale of business: we have excluded the impact of the loss on the sale of a business as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the

adjustment of this loss supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.

The non-GAAP adjustments reflect the following:

(1) During the first quarter of fiscal 2021, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030. We used a portion of the proceeds to redeem all of our outstanding 6.125% senior notes due 2023. As a result of our redemption of the 2023 Notes, we incurred incremental expenses of approximately $10.0 million, comprised of a call premium payment of $6.1 million, overlapping interest expense of approximately $1.4 million and a $2.5 million non-cash charge for the write-off of unamortized financing costs. These amounts are included in Interest expense in the condensed consolidated statements of operations.

(2) During the first quarter of fiscal 2021, we recognized a loss of $2.6 million, included in selling, general and administrative expense in the consolidated statement of operations, from the sale of our Breeder’s Choice business unit after concluding it was not a strategic business for our Pet segment.

(in thousands, except per share amounts)

Net Income and Diluted Net Income Per Share Reconciliation GAAP to Non-GAAP Reconciliation For the Three Months Ended June 25, 2022 June 26, 2021 For the Nine Months Ended June 25, 2022 June 26, 2021
GAAP net income attributable to Central Garden & Pet Company $75,420 $76,186 $154,142 $154,753
Incremental expenses from note redemption and issuance (1) — — — 9,952
Loss on sale of business (2) — — — 2,611
Tax effect of incremental redemption expenses and loss on sale $— $— — (2,825)
Non-GAAP net income attributable to Central Garden & Pet Company $75,420 $76,186 $154,142 $164,491
GAAP diluted net income per share $1.39 $1.37 $2.82 $2.80
Non-GAAP diluted net income per share $1.39 $1.37 $2.82 $2.98
Shares used in GAAP and non-GAAP diluted net earnings per share calculation 54,329 55,658 54,658 55,236

Organic Net Sales Reconciliation

We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.

(in millions)

Consolidated GAAP to Non-GAAP Reconciliation For Three Months Ended June 25, 2022 Net sales (GAAP) Effect of acquisition & divestitures on increase in net sales Net sales organic For the Nine Months Ended June 25, 2022 Net sales (GAAP) Effect of acquisition & divestitures on increase in net sales Net sales organic
Q3 FY 22 $1,015.4 $25.1 $990.3 $2,631.1 $146.9 $2,484.2
Q3 FY 21 1,037.1 — 1,037.1 2,564.6 3.9 2,560.7
$ increase (decrease) $(21.7) $(46.8) $66.5 $(76.5)
% increase (decrease) (2.1)% (4.5)% 2.6% (3.0)%

(in millions)

Pet GAAP to Non-GAAP Reconciliation For Three Months Ended June 25, 2022 Net sales (GAAP) Effect of acquisition & divestitures on increase in net sales Net sales organic For the Nine Months Ended June 25, 2022 Net sales (GAAP) Effect of acquisition & divestitures on increase in net sales Net sales organic
Q3 FY 22 $504.8 $— $504.8 $1,438.4 $— $1,438.4
Q3 FY 21 507.8 — 507.8 1,436.2 3.9 1,432.3
$ increase $(3.0) $(3.0) $2.2 $6.1
% increase (0.6)% (0.6)% 0.2% 0.4%

(in millions)

Garden GAAP to Non-GAAP Reconciliation For Three Months Ended June 25, 2022 Net sales (GAAP) Effect of acquisition & divestitures on increase in net sales Net sales organic For the Nine Months Ended June 25, 2022 Net sales (GAAP) Effect of acquisition & divestitures on increase in net sales Net sales organic
Q3 FY 22 $510.6 $25.1 $485.5 $1,192.7 $146.9 $1,045.8
Q3 FY 21 529.3 — 529.3 1,128.4 — 1,128.4
$ increase (decrease) $(18.7) $(43.8) $64.3 $(82.6)
% increase (decrease) (3.5)% (8.3)% 5.7% (7.3)%

(in thousands)

Adjusted EBITDA Reconciliation GAAP to Non-GAAP Reconciliation For the Three Months Ended June 25, 2022 Garden Pet Corp Total
Net income attributable to Central Garden & Pet Company $— $— $— $75,420
Interest expense, net — — — 14,335
Other expense — — — 759
Income tax expense — — — 23,430
Net income attributable to noncontrolling interest — — — 135
Sum of items below operating income — — — 38,659
Income (loss) from operations $75,564 $62,616 $(24,101) $114,079
Depreciation & amortization 9,118 9,791 975 19,884
Noncash stock-based compensation — — 7,400 7,400
Adjusted EBITDA $84,682 $72,407 $(15,726) $141,363

30

(in thousands)

Adjusted EBITDA Reconciliation GAAP to Non-GAAP Reconciliation For the Three Months Ended June 26, 2021 Garden Pet Corp Total
Net income attributable to Central Garden & Pet Company $— $— $— $76,186
Interest expense, net — — — 13,086
Other expense — — — 1,086
Income tax expense — — — 22,315
Net income attributable to noncontrolling interest — — — 568
Sum of items below operating income — — — 37,055
Income (loss) from operations $67,037 $71,021 $(24,817) $113,241
Depreciation & amortization 10,808 8,960 1,222 20,990
Noncash stock-based compensation — — 6,646 6,646
Adjusted EBITDA $77,845 $79,981 $(16,949) $140,877

(in thousands)

Adjusted EBITDA Reconciliation GAAP to Non-GAAP Reconciliation For the Nine Months Ended June 25, 2022 Garden Pet Corp Total
Net income attributable to Central Garden & Pet Company $— $— $— $154,142
Interest expense, net — — — 43,445
Other expense — — — 1,337
Income tax expense — — — 47,319
Net income attributable to noncontrolling interest — — — 895
Sum of items below operating income — — — 92,996
Income (loss) from operations $152,132 $168,512 $(73,506) $247,138
Depreciation & amortization 26,457 28,879 2,997 58,333
Noncash stock-based compensation — — 18,879 18,879
Adjusted EBITDA $178,589 $197,391 $(51,630) $324,350

(in thousands)

Adjusted EBITDA Reconciliation GAAP to Non-GAAP Reconciliation For the Nine Months Ended June 26, 2021 Garden Pet Corp Total
Net income attributable to Central Garden & Pet Company $— $— $— $154,753
Interest expense, net — — — 44,006
Other income — — — (370)
Income tax expense — — — 45,260
Net income attributable to noncontrolling interest — — — 1,242
Sum of items below operating income — — — 90,138
Income (loss) from operations $137,650 $176,604 $(69,363) $244,891
Depreciation & amortization 22,250 26,927 3,582 52,759
Noncash stock-based compensation — — 17,040 17,040
Adjusted EBITDA $159,900 $203,531 $(48,741) $314,690

31

Inflation

Our revenues and margins are dependent on various economic factors, including rates of inflation, energy costs, currency fluctuations, and other macro-economic factors which may impact levels of consumer spending. In fiscal 2022, we have been adversely impacted by rising input costs related to inflation, particularly relating to grain and seed prices, fuel prices and the ingredients used in our garden controls and fertilizers. Rising costs have made it difficult for us to increase prices to our retail customers at a pace sufficient to enable us to maintain margins.

In fiscal 2022, we have continued to experience increasing inflationary pressure, including notable increases in costs for key commodities, materials, labor and freight.

Weather and Seasonality

Our sales of lawn and garden products are influenced by weather and climate conditions in the different markets we serve. Our Garden segment’s business is highly seasonal. In fiscal 2021, approximately 69% of our Garden segment’s net sales and 60% of our total net sales occurred during our second and third fiscal quarters. Substantially all of the Garden segment’s operating income is typically generated in this period, which has historically more than offset the operating loss incurred during the first fiscal quarter of the year. However, in fiscal 2022, we experienced a poor garden season due to unfavorable weather.

Liquidity and Capital Resources

We have financed our growth through a combination of internally generated funds, bank borrowings, supplier credit, and sales of equity and debt securities to the public.

Our business is seasonal and our working capital requirements and capital resources track closely to this seasonal pattern. Generally, during the first fiscal quarter, accounts receivable reach their lowest level while inventory, accounts payable and short-term borrowings begin to increase. During the second fiscal quarter, receivables, accounts payable and short-term borrowings increase, reflecting the build-up of inventory and related payables in anticipation of the peak lawn and garden selling season. During the third fiscal quarter, inventory levels remain relatively constant while accounts receivable peak and short-term borrowings start to decline as cash collections are received during the peak selling season. During the fourth fiscal quarter, inventory levels are at their lowest, and accounts receivable and payables are substantially reduced through conversion of receivables to cash.

We service two broad markets: pet supplies and lawn and garden supplies. Our pet supplies businesses involve products that have a year round selling cycle with a slight degree of seasonality. As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our lawn and garden businesses are highly seasonal with approximately 69% of our Garden segment’s net sales occurring during the second and third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods. To encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended credit terms and/or promotional discounts.

Operating Activities

Net cash used by operating activities increased by $261.0 million, from $178.6 million of cash provided by operating activities for the nine months ended June 26, 2021, to cash used by operating activities of $82.4 million for the nine months ended June 25, 2022. The increase in cash used by operating activities was due primarily to changes in our working capital accounts for the period ended June 25, 2022, as compared to the prior year period, predominantly an increase in accounts receivable and inventory resulting from an intentional build-up in inventory due to the increased demand for our products amid the continuing global supply chain issues, as well as increased input costs.

Investing Activities

Net cash used in investing activities decreased $688.1 million, from $788.9 million for the nine months ended June 26, 2021 to $100.8 million during the nine months ended June 25, 2022. The decrease in cash used in investing activities was due primarily to the three acquisitions in the prior nine-month period, partially offset by an increase in capital expenditures of $41.6 million in the current year compared to the prior year. During the first quarter of fiscal 2021, we acquired DoMyOwn for approximately $81 million. During the second quarter of fiscal 2021, we acquired Hopewell Nursery on December 31, 2020 for approximately $81 million and Green Garden Products on February 11, 2021 for approximately $571 million.

Financing Activities

Net cash used by financing activities increased $517.3 million, from $471.1 million of cash provided for the nine months ended June 26, 2021, to $46.2 million of cash used for the nine months ended June 25, 2022. The increase in cash used by financing activities during the current year was due primarily to the issuance of $500 million of our 2030 Notes in October 2020 and net borrowings under our senior secured credit facility of $190 million in the prior year period, partially offset by the repayment of our 2023 Notes and the corresponding premium paid on extinguishment in November 2020, as well as debt issuance costs incurred on the issuance of the 2030 Notes. We also recommenced open market purchases of our common stock during the current year period. During the nine months ended June 25, 2022, we repurchased approximately 13 thousand shares of our voting common stock (CENT) on the open market at an aggregate cost of approximately $0.6 million, or approximately $41.30 per share, and 0.9 million shares of our non-voting Class A common stock (CENTA) on the open market at an aggregate cost of approximately $37.7 million, or approximately $41.44 per share. During the nine months ended June 26, 2021, we did not make any open market purchases of our common stock.

We expect that our principal sources of funds will be cash generated from our operations and, if necessary, borrowings under our $750 million Amended Credit Facility. Based on our anticipated cash needs, availability under our asset backed revolving credit facility and the scheduled maturity of our debt, we believe that our sources of liquidity should be adequate to meet our working capital, capital spending and other cash needs for at least the next 12 months. However, we cannot assure you that these sources will continue to provide us with sufficient liquidity and, should we require it, that we will be able to obtain financing on terms satisfactory to us, or at all.

We believe that cash flows from operating activities, funds available under our asset backed loan facility, and arrangements with suppliers will be adequate to fund our presently anticipated working capital and capital expenditure requirements for the foreseeable future. We anticipate that our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also investment in our continued implementation of a scalable enterprise-wide information technology platform, will be approximately $115 million to $125 million in fiscal 2022, of which we have invested approximately $99 million through June 25, 2022.

As part of our growth strategy, we have acquired a number of companies in the past, and we anticipate that we will continue to evaluate potential acquisition candidates in the future. If one or more potential acquisition opportunities, including those that would be material, become available in the near future, we may require additional external capital. In addition, such acquisitions would subject us to the general risks associated with acquiring companies, particularly if the acquisitions are relatively large.

Total Debt

At June 25, 2022, our total debt outstanding was $1,186.2 million, as compared with $1,183.7 million at June 26, 2021.

Senior Notes

Issuance of $400 million 4.125% Senior Notes due 2031

In April 2021, we issued $400 million aggregate principal amount of 4.125% senior notes due April 2031 (the "2031 Notes"). We used the net proceeds from the offering to repay all outstanding borrowings under our Amended Credit Facility, with the remainder to be used for general corporate purposes.

We incurred approximately $6 million of debt issuance costs in conjunction with this issuance, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2031 Notes.

The 2031 Notes require semi-annual interest payments on April 30 and October 30, which commenced October 30, 2021. The 2031 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our Amended Credit Facility. The 2031 Notes were issued in a private placement under Rule 144A and will not be registered under the Securities Act of 1933.

We may redeem some or all of the 2031 Notes at any time, at our option, prior to April 30, 2026 at the principal amount plus a "make whole" premium. At any time prior to April 30, 2024, we may also redeem, at our option, up to 40% of the notes with the proceeds of certain equity offerings at a redemption price of 104.125% of the principal amount of the notes. We may redeem some or all of the 2031 Notes at our option, at any time on or after April 30, 2026 for 102.063%, on or after April 30, 2027 for 101.375%, on or after April 30, 2028 for 100.688% and on or after April 30, 2029 for 100.0%, plus accrued and unpaid interest.

The holders of the 2031 Notes have the right to require us to repurchase all or a portion of the 2031 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest, upon the occurrence of specific kinds of changes of control.

The 2031 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of June 25, 2022.

Issuance of $500 million 4.125% Senior Notes due 2030

In October 2020, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030 (the "2030 Notes"). In November 2020, we used a portion of the net proceeds to redeem all of our outstanding 6.125% senior notes due November 2023 (the "2023 Notes") at a redemption price of 101.531% plus accrued and unpaid interest, and to pay related fees and expenses, with the remainder for general corporate purposes.

We incurred approximately $8.0 million of debt issuance costs associated with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2030 Notes.

As a result of our redemption of the 2023 Notes, we incurred a call premium payment of $6.1 million, overlapping interest expense for 30 days of approximately $1.4 million and a $2.5 million non-cash charge for the write-off of unamortized deferred financing costs related to the 2023 Notes. These amounts are included in interest expense in the condensed consolidated statements of operations.

The 2030 Notes require semiannual interest payments on October 15 and April 15. The 2030 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our senior secured revolving credit facility or guarantee our other debt.

We may redeem some or all of the 2030 Notes at any time, at our option, prior to October 15, 2025 at a price equal to 100% of the principal amount plus a “make-whole” premium. Prior to October 15, 2023, we may redeem up to 40% of the original aggregate principal amount of the notes with the proceeds of certain equity offerings at a redemption price of 104.125% of the principal amount of the notes. We may redeem some or all of the 2030 Notes, at our option, in whole or in part, at any time on or after October 15, 2025 for 102.063%, on or after October 15, 2026 for 101.375%, on or after October 15, 2027 for 100.688% and on or after October 15, 2028 for 100.0%, plus accrued and unpaid interest.

The holders of the 2030 Notes have the right to require us to repurchase all or a portion of the 2030 Notes at a purchase price equal to 101.0% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2030 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of June 25, 2022.

$300 Million 5.125% Senior Notes due 2028

In December 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). We used the net proceeds from the offering to finance acquisitions and for general corporate purposes.

We incurred approximately $4.8 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

The 2028 Notes require semiannual interest payments on February 1 and August 1. The 2028 Notes are unconditionally guaranteed on a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our senior secured revolving credit facility or who guarantee the 2030 Notes.

We may redeem some or all of the 2028 Notes at any time, at our option, prior to January 1, 2023 at the principal amount plus a “make whole” premium. We may redeem some or all of the 2028 Notes, at our option, at any time on or after January 1, 2023 for 102.563%, on or after January 1, 2024 for 101.708%, on or after January 1, 2025 for 100.854% and on or after January 1, 2026 for 100.0%, plus accrued and unpaid interest.

The holders of the 2028 Notes have the right to require us to repurchase all or a portion of the 2028 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of June 25, 2022.

Asset-Based Loan Facility Amendment

On December 16, 2021, we entered into a Third Amended and Restated Credit Agreement (“Amended Credit Agreement”). The Amended Credit Agreement amended and restated the previous credit agreement dated September 27, 2019 (the "Predecessor Credit Agreement"), and has been increased to provide for a $750 million principal amount senior secured asset-based revolving credit facility, with up to an additional $400 million principal amount available with the consent of the Lenders, as defined, if we exercise the uncommitted accordion feature set forth therein (collectively, the “Amended Credit Facility”). The Amended Credit Facility matures on December 16, 2026. We may borrow, repay and reborrow amounts under the Amended Credit Facility until its maturity date, at which time all amounts outstanding under the Amended Credit Facility must be repaid in full.

The Amended Credit Facility is subject to a borrowing base that is calculated using a formula based upon eligible receivables and inventory, and at our election, eligible real property, minus certain reserves. We did not draw down any commitments under the Amended

Credit Facility upon closing. Proceeds of the Amended Credit Facility will be used for general corporate purposes. Net availability under the Amended Credit Facility was approximately $556 million as of June 25, 2022. The Amended Credit Facility includes a $50 million sublimit for the issuance of standby letters of credit and a $75 million sublimit for short-notice borrowings. As of June 25, 2022, there were no borrowings outstanding and no letters of credit outstanding under the Amended Credit Facility. There were other letters of credit of $1.3 million outstanding as of June 25, 2022.

Borrowings under the Amended Credit Facility will bear interest at an index based on LIBOR (which will not be less than 0.00%) or, at our option, the Base Rate, plus, in either case, an applicable margin based on our usage under the credit facility. Base Rate is defined as the highest of (a) the Truist prime rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month LIBOR plus 1.00% and (d) 0.00%. The applicable margin for LIBOR-based borrowings fluctuates between 1.00%-1.50%, and was 1.25% as of June 25, 2022, and such applicable margin for Base Rate borrowings fluctuates between 0.00%-0.50%, and was 0.25% as of June 25, 2022. An unused line fee shall be payable quarterly in respect of the total amount of the unutilized Lenders’ commitments and short-notice borrowings under the Amended Credit Facility. Letter of credit fees at the applicable margin on the average undrawn and unreimbursed amount of letters of credit shall be payable quarterly and a facing fee of 0.125% shall be payable quarterly for the stated amount of each letter of credit. We are also required to pay certain fees to the administrative agent under the Amended Credit Facility. The Amended Credit Facility provides for the transition from LIBOR to SOFR and does not require an amendment in connection with such transition. As of June 25, 2022, the applicable interest rate related to Base Rate borrowings was 5.0%, and the applicable interest rate related to one-month LIBOR-based borrowings was 2.9%.

We incurred approximately $2.4 million of debt issuance costs in conjunction with this transaction, which included lender fees and legal expenses. The debt issuance costs are being amortized over the term of the Amended Credit Facility.

The Amended Credit Facility continues to contain customary covenants, including financial covenants which require us to maintain a minimum fixed charge coverage ratio of 1:1 upon triggered quarterly testing (e.g. when availability falls below certain thresholds established in the agreement), reporting requirements and events of default. The Amended Credit Facility is secured by substantially all assets of the borrowing parties, including (i) pledges of 100% of the stock or other equity interest of each domestic subsidiary that is directly owned by such entity and (ii) 65% of the stock or other equity interest of each foreign subsidiary that is directly owned by such entity, in each case subject to customary exceptions. We were in compliance with all financial covenants under the Amended Credit Facility during the period ended June 25, 2022.

Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities

Central (the "Parent/Issuer") issued $400 million of 2031 Notes in April 2021, $500 million of 2030 Notes in October 2020, and $300 million of 2028 Notes in December 2017. The 2031 Notes, 2030 Notes and 2028 Notes are fully and unconditionally guaranteed on a joint and several senior basis by each of our existing and future domestic restricted subsidiaries (the "Guarantors") which are guarantors of our senior secured revolving credit facility ("Credit Facility"). The 2031 Notes, 2030 Notes and 2028 Notes are unsecured senior obligations and are subordinated to all of our existing and future secured debt, including our Amended Credit Facility, to the extent of the value of the collateral securing such indebtedness. There are no significant restrictions on the ability of the Guarantors to make distributions to the Parent/Issuer. Certain subsidiaries and operating divisions of the Company do not guarantee the 2031, 2030 or 2028 Notes and are referred to as the Non-Guarantors.

The Guarantors jointly and severally, and fully and unconditionally, guarantee the payment of the principal and premium, if any, and interest on the 2031, 2030 and 2028 Notes when due, whether at stated maturity of the 2031, 2030 and 2028 Notes, by acceleration, call for redemption or otherwise, and all other obligations of the Company to the holders of the 2031, 2030 and 2028 Notes and to the trustee under the indenture governing the 2031, 2030 and 2028 Notes (the "Guarantee"). The Guarantees are senior unsecured obligations of each Guarantor and are of equal rank with all other existing and future senior indebtedness of the Guarantors.

The obligations of each Guarantor under its Guarantee shall be limited to the maximum amount as well, after giving effect to all other contingent and fixed liabilities of such Guarantor and to any collections from or payments made by or on behalf of any other Guarantor in respect of the obligations of such Guarantor under the guarantee not constituting a fraudulent conveyance or fraudulent transfer under Federal or state law.

The Guarantee of a Guarantor will be released:

(1) upon any sale or other disposition of all or substantially all of the assets of that Guarantor (including by way of merger or consolidation), in accordance with the governing indentures, to any person other than the Company;

(2) if such Guarantor merges with and into the Company, with the Company surviving such merger;

(3) if the Guarantor is designated as an Unrestricted Subsidiary; or

(4) if the Company exercises its legal defeasance option or covenant defeasance option or the discharge of the Company's obligations under the indentures in accordance with the terms of the indentures.

The following tables present summarized financial information of the Parent/Issuer subsidiaries and the Guarantor subsidiaries. All intercompany balances and transactions between subsidiaries under Parent/Issuer and subsidiaries under the Guarantor have been eliminated. The information presented below excludes eliminations necessary to arrive at the information on a consolidated basis. In presenting the summarized financial statements, the equity method of accounting has been applied to the Parent/Issuer's interests in the Guarantor Subsidiaries. The summarized information excludes financial information of the Non-Guarantors, including earnings from and investments in these entities.

(in thousands)

Summarized Statements of Operations Nine Months Ended June 25, 2022 Parent/Issuer Guarantors Fiscal Year Ended September 25, 2021 Parent/Issuer Guarantors
Net sales $634,181 $1,738,486 $908,599 $2,142,925
Gross profit $146,457 $559,947 $205,837 $686,332
Income from operations $2,289 $212,717 $4,382 $229,961
Equity in earnings of Guarantor subsidiaries $163,588 $— $183,122 $—
Net income (loss) $(31,435) $163,588 $(45,596) $183,122

Summarized Balance Sheet Information

(in thousands)

As of June 25, 2022 Parent/Issuer Guarantors As of September 25, 2021 Parent/Issuer Guarantors
Current assets $468,665 $968,644 $670,030 $733,132
Intercompany receivable from Non-guarantor subsidiaries 294,560 61,648 229,795 61,633
Other assets 3,080,775 2,407,481 2,896,162 2,399,165
Total assets $3,844,000 $3,437,773 $3,795,987 $3,193,930
Current liabilities $160,538 $308,367 $185,996 $298,039
Long-term debt 1,185,421 — 1,184,024 —
Other liabilities 1,401,475 217,895 1,272,798 151,011
Total liabilities $2,747,434 $526,262 $2,642,818 $449,050

Contractual Obligations

There have been no material changes outside the ordinary course of business in our contractual obligations set forth in the Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources in our Annual Report on Form 10-K for the fiscal year ended September 25, 2021.

New Accounting Pronouncements

Refer to Footnote 1 in the notes to the condensed consolidated financial statements for new accounting pronouncements.

Critical Accounting Policies, Estimates and Judgments

There have been no material changes to our critical accounting policies, estimates and assumptions or the judgments affecting the application of those accounting policies since our Annual Report on Form 10-K for the fiscal year ended September 25, 2021.

Market risk

As filed, 164 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the fiscal year ended September 25, 2021.

Controls and procedures

As filed, 1,413 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures. Our Chief Executive Officer and principal financial officer have reviewed, as of the end of the period covered by this report, the “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) that ensure that information relating to the Company required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported in a timely and proper manner and that such information is accumulated and communicated to our management, including our Chief Executive Officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based upon this review, such officers concluded that our disclosure controls and procedures were effective as of June 25, 2022.

(b) Changes in Internal Control Over Financial Reporting. Our management, with the participation of our Chief Executive Officer and our principal financial officer, have evaluated whether any change in our internal control over financial reporting occurred during the third quarter of fiscal 2022. There were no changes in our internal control over financial reporting during the third quarter of fiscal 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 162 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 25, 2021.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-25. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-03-27 to 2022-06-25$1.02bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2021-09-26 to 2022-06-25$2.63bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-03-27 to 2022-06-25$707.8mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2021-09-26 to 2022-06-25$1.84bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-03-27 to 2022-06-25$307.6mus-gaap:GrossProfit
Gross profit9 months2021-09-26 to 2022-06-25$792.6mus-gaap:GrossProfit
Selling, general and administrative3 months2022-03-27 to 2022-06-25$193.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2021-09-26 to 2022-06-25$545.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-03-27 to 2022-06-25$114.1mus-gaap:OperatingIncomeLoss
Operating income9 months2021-09-26 to 2022-06-25$247.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-03-27 to 2022-06-25$14.4mus-gaap:InterestExpense
Interest expense9 months2021-09-26 to 2022-06-25$43.6mus-gaap:InterestExpense
Income tax3 months2022-03-27 to 2022-06-25$23.4mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2021-09-26 to 2022-06-25$47.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-03-27 to 2022-06-25$75.4mus-gaap:NetIncomeLoss
Net income9 months2021-09-26 to 2022-06-25$154.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-03-27 to 2022-06-25$1.39us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2021-09-26 to 2022-06-25$2.82us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-03-27 to 2022-06-25$1.42us-gaap:EarningsPerShareBasic
Basic EPS9 months2021-09-26 to 2022-06-25$2.89us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-03-27 to 2022-06-2554,329,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2021-09-26 to 2022-06-2554,658,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2021-09-26 to 2022-06-25−$82.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2021-09-26 to 2022-06-25$98.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2021-09-26 to 2022-06-25$41.8mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-06-25$195.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-06-25$1.63bnus-gaap:AssetsCurrent
Total assetsAt period end2022-06-25$3.35bnus-gaap:Assets
Current liabilitiesAt period end2022-06-25$516.2mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2022-06-25$1.19bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-06-25$352.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-06-25$1.35bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000887733-22-000013. Last ingested by Listed: Nov 10, 2026, 04:49 ET. Listed shows no prices and gives no investment advice.